CSIMarket


Quidel Corp  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quidel Corp

QDEL's Fundamental analysis






Looking into Quidel growth rates, revenue grew by 431.75 % in IV. Quarter 2020 from the same quarter a year ago. Ranking at No. 74

Biotechnology & Drugs industry recorded growth of revenues by 15.48 %

Quidel's net income grew by 1435.07 % in IV. Quarter 2020 year on year, above company average,

More on QDEL's Growth


Quidel
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Quidel PEG ratio is at 0.01 , above Biotechnology & Drugs industry PEG average of 0.
Company
9.2
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 6.32.
Biotechnology & Drugs industry's Price to Sales ratio is at 20.85.

Quidel Price to Book Ratio is at 7.87 lower than Indusry Avg. of 631.79. and higher than S&P 500 Avg. of 0.14

More on QDEL's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.25
 Tangible Book Value (Per Share $) 10.17

Quidel
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Quidel PEG ratio is at 0.01 , above Biotechnology & Drugs industry PEG average of 0.
Company
9.2
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 6.32.
Biotechnology & Drugs industry's Price to Sales ratio is at 20.85.

Quidel Price to Book Ratio is at 7.87 lower than Indusry Avg. of 631.79. and higher than S&P 500 Avg. of 0.14

More on QDEL's Valuation

  Market Capitalization (Millions $) 10,494
  Shares Outstanding (Millions) 86
  Employees -
  Revenues (TTM) (Millions $) 1,662
  Net Income (TTM) (Millions $) 810
  Cash Flow (TTM) (Millions $) 437
  Capital Exp. (TTM) (Millions $) -65
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.25
  Tangible Book Value (Per Share $) 10.17

  Market Capitalization (Millions $) 10,494
  Shares Outstanding (Millions) 86
  Employees -
  Revenues (TTM) (Millions $) 1,662
  Net Income (TTM) (Millions $) 810
  Cash Flow (TTM) (Millions $) 437
  Capital Exp. (TTM) (Millions $) -65

QDEL's Profitability Comparisons
Quidel achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2020 to 76.26 % from 64.69 % in III. Quarter.

Quidel net profit margin of 58.1 % is currently ranking no. 9 in Biotechnology & Drugs industry, ranking no. 38 in Healthcare sector and number 193 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.39
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.62
  Asset Turnover Ratio (TTM) 1.31
  Inventory Turnover Ratio (TTM) 3.47



Quidel achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2020 to 76.26 % from 64.69 % in III. Quarter.

Quidel net profit margin of 58.1 % is currently ranking no. 9 in Biotechnology & Drugs industry, ranking no. 38 in Healthcare sector and number 193 in S&P 500.

More on QDEL's Key Ratios





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HEPA's Profile

Stock Price

HEPA's Financials

Business Description

Fundamentals

Charts & Quotes

HEPA's News

Suppliers

HEPA's Competitors

Customers & Markets

Economic Indicators

HEPA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071